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system controls the course of experimental
autoimmune encephalomyelitis independently of
the localization and composition of inflammatory
foci
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Abstract
Background: Murine experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, presents
typically as ascending paralysis. However, in mice in which interferon-gamma (IFNg) signaling is disrupted by
genetic deletion, limb paralysis is accompanied by atypical deficits, including head tilt, postural imbalance, and
circling, consistent with cerebellar/vestibular dysfunction. This was previously attributed to intense cerebellar and
brainstem infiltration by peripheral immune cells and formation of neutrophil-rich foci within the CNS. However,
the exact mechanism by which IFNg signaling prohibits the development of vestibular deficits, and whether the
distribution and composition of inflammatory foci within the CNS affects the course of atypical EAE remains
elusive.
Methods: We induced EAE in IFNg-/- mice and bone marrow chimeric mice in which IFNgR is not expressed in the
CNS but is intact in the periphery (IFNgRCNSKO) and vice versa (IFNgRperiKO). Blood-brain barrier permeability was
determined by Evans blue intravenous administration at disease onset. Populations of immune cell subsets in the
periphery and the CNS were quantified by flow cytometry. CNS tissues isolated at various time points after EAE
induction, were analyzed by immunohistochemistry for composition of inflammatory foci and patterns of axonal
degeneration.
Results: Incidence and severity of atypical EAE were more pronounced in IFNgRCNSKO as compared to IFNgRperiKO
mice. Contrary to what we anticipated, cerebella/brainstems of IFNgRCNSKO mice were only minimally infiltrated,
while the same areas of IFNgRperiKO mice were extensively populated by peripheral immune cells. Furthermore, the
CNS of IFNgRperiKO mice was characterized by persistent neutrophil-rich foci as compared to IFNgRCNSKO.
Immunohistochemical analysis of the CNS of IFNg-/- and IFNgR chimeric mice revealed that IFNg protective actions
are exerted through microglial STAT1.
Conclusions: Alterations in distribution and composition of CNS inflammatory foci are not sufficient for the onset
of atypical EAE. IFNg dictates the course of neuroinflammatory disorders mainly through actions exerted within the
CNS. This study provides strong evidence that link microglial STAT1 inactivation to vestibular dysfunction.
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Introduction
Experimental autoimmune encephalomyelitis (EAE) is
the most commonly used animal model for multiple
sclerosis (MS). Similar to MS, animals with EAE exhibit
activation of immune cells in peripheral immune organs,
migration of these cells into the CNS, and establishment
of multifocal inflammation, demyelination and damage
to neurons and axons. Cumulative axonal loss eventually
leads to severe and permanent neurological deficits [1,2].
In classical EAE, most neurological deficits are attributa-
ble to spinal cord lesions. Interestingly, mice in which
IFNg signaling has been genetically disrupted (IFNg-/-,
or IFNgR-/- mice), also show evidences of cerebellar/
vestibular dysfunction, deficits that are regarded as aty-
pical EAE features. Such deficits in MS patients are
associated with poor prognosis [3-5]. This atypical EAE
course is behaviorally characterized by deficits such as
axial rotation, circling behavior, and balance impair-
ment. In this study we sought to determine the mechan-
isms by which interrupted IFNg signaling leads to this
atypical course.
IFNg is a multifunctional cytokine that is involved in
the initiation and establishment of inflammation, and
participates in both innate and adaptive immune
responses. T and NK cells are the main sources of IFNg
[6,7] but it can be induced in many other cell types
including neurons [8,9]. IFNg is also crucial for the reso-
lution of inflammation by inducing apoptosis of acti-
vated lymphocytes, supporting Treg function, and
restricting the development of T cell subsets associated
with autoimmunity [10,11]. Thus, the exacerbation of
neurological disability in animals with EAE in the
absence of IFNg or its receptor has been attributed in
the past to uncontrollable expansion of pathogenic
immune cells in the periphery [12-14].
However, IFNg has yet-to-be fully defined actions on
neurons, astrocytes, oligodendrocytes and microglia, all
of which express IFNgR [8,15-20]. It is possible that
IFNg acts as a disease-limiting agent within the CNS but
not in peripheral immune tissues. This would explain
why peripherally administered IFNg has no effect on the
course of EAE, while intraventricularly administered
IFNg alleviates or resolves the neurological deficits
[21-23].
Alternatively, the protective effect of IFNg signaling in
EAE may be exerted both in peripheral immune cells
and within the CNS [22,24,25]. Passively transferred
EAE is characterized by increased cerebellar/brainstem
infiltration and atypical neurological deficits when IFNg
signaling is disrupted in either the recipient mouse or
the donor cells [24]. One drawback of passively trans-
ferred EAE, however, is that immune cells from the reci-
pient animal are also activated and migrate into the
CNS parenchyma along with those of the donor [26,27],
thus making it challenging to dissociate peripheral from
CNS events. Furthermore, passively transferred IFNg-/-
cells will also perturb IFNg induced signaling in CNS
resident cells; this is because, in EAE, infiltrating
immune cells are the major IFNg source in the CNS.
For these reasons, it remains unclear whether the devel-
opment of atypical deficits in the absence of IFNg is due
to effects on peripheral immune cells before or after
they enter the CNS, or directly on CNS resident cells.
Finally, although in EAE mice without IFNg signaling,
infiltration of the cerebellum or brainstem by peripheral
immune cells has been considered sufficient for the
development of atypical deficits, EAE-susceptible mouse
strains with intact IFNg signaling show infiltration of
these areas but never develop atypical deficits [28-30].
In this study, we re-visited the role(s) of IFNg signal-
ing in the genesis of atypical EAE. We initially charac-
terized the disease process in IFNg-/- mice. Then, to
differentiate between peripheral and CNS-restricted
roles of IFNg signaling, we constructed irradiation bone
marrow chimeric mice in which IFNgR was expressed in
radioresistant CNS cells but not in radiosensitive periph-
eral immune cells or vice versa.
Our data shows that active EAE induction in mice
lacking IFNgR in the CNS results in more frequent and
more severe atypical neurological deficits compared to
mice lacking IFNgR in peripheral immune cells. This
difference in incidence of atypical EAE was not attribu-
table to more extensive cerebellar infiltration, preferen-
tial recruitment of pathogenic immune cell subsets
within the CNS, or increased axonopathy. Instead, our
data are consistent with the hypothesis that IFNg exerts
protective actions against vestibular/brainstem/cerebellar




IFNg-/- and IFNgRKO, C57BL/6 (C57BL/6CD45.2) mice
and B6.SJL-Ptprca Pepcb/BoyJ (C57BL/6CD45.1) were
purchased from Jackson Laboratory. Both males and
females (matched per experiment) were used. Mice were
housed in a pathogen-free facility. All experimental pro-
tocols were approved by the Institutional Animal Care
and Use Committee of the University of California,
Davis.
Generation of bone marrow chimeras (BMC)
Recipient mice (6 weeks old) were irradiated with 950
rads (Cs-137 source, MK1-30 irradiator, J.L Shepherd
and Assoc.) 18 to 24 hours before bone marrow transfer,
and treated with antibiotic water (sulfamethoxazole, Hi-
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Tech Pharmacal) for two weeks thereafter. Bone marrow
cells were harvested from femurs and tibias of donor
mice and red blood cells were lysed with ACK solution
(Quality Biological) for 3 min at 37°C. T cells were
removed by complement mediated lysis, by resuspend-
ing bone marrow cells at a concentration of 107 cells/
mL in Cytotoxic media, RPMI-1640 containing 25 mM
Hepes buffer and 0.3% bovine serum albumin, followed
by successive incubation with Thy1.2 antibody (1:500,
CEDARLANE) at 4°C for 30 min and Low Tox M rabbit
complement (1:10, CEDARLANE) at 37°C for 30 min.
Cells were resuspended in PBS and counted. Ten mil-
lion bone marrow cells in 150 μl were injected into the
recipient mice via tail vein injection the day after lethal
irradiation. EAE was induced 6 to 8 weeks post bone
marrow reconstitution. BMC constructed are described
in Table 1.
EAE induction
EAE was induced as previously described [1]. Briefly, 300
μg of rodent MOG peptide (amino acids 35-55, New
England Peptides) in CFA containing 5 mg/ml killed
Mycobacterium tuberculosis (Difco) were administered
subcutaneously in the flank to age-matched (11-14
weeks-old) mice on day 0. Non-irradiated mice received
200 ng of pertussis toxin and bone marrow chimeras 50
ng of pertussis toxin intraperitoneally on days 0 and 2.
Both classical and atypical neurological deficits were eval-
uated daily until day 35 post immunization (pi). Classic
neurological deficits were graded as follows: limp tail or
waddling gait = 1; limp tail and waddling gait = 2; single
limb paresis and ataxia 2.5; double limb paresis = 3; sin-
gle limb paralysis and paresis of second limb = 3.5; full
paralysis of 2 limbs = 4; moribund = 4.5; and death = 5
[1,31]. Atypical neurological deficits were graded as pre-
viously described [32] with slight modifications: Mild
head tilting = 1, severe head tilting = 2, body tilting = 3,
involuntary and continuous axial rotation = 4.
Mapping areas of blood brain barrier breakdown by
Evans blue
Mice were intravenously injected with 200 μl of 2.5%
Evans blue (Sigma) in saline. Ninety minutes later, mice
were anesthetized by intraperitoneal injection of keta-
mine (150 mg/kg) and xylazine (16 mg/kg) and intracar-
dially perfused with ice cold PBS, followed by 4%
paraformaldehyde (PFA) in PBS. The brains and spinal
cords were harvested, post-fixed in 4% PFA overnight at
4°C. The next day, tissues were sectioned at sites of
Evans blue staining and photographed using the Zeiss
SteREO Lumar.V12.
Isolation of leukocytes from mouse spleen/lymph nodes
and CNS
Mice sacrificed by CO2 asphyxiation were perfused with
ice cold PBS. Spleens and draining lymph nodes were
harvested, combined, minced in PBS, and pushed with
the back of a syringe plunger through a 40 μm mesh.
Red blood cells were lysed with ACK solution (Quality
Biologicals). Brains and spinal cords were minced,
digested at 37°C for 30 min in PBS containing 0.04
units of Liberase R1 (Roche) and 10 μg of DNase I
(Roche) per ml. Softened fragments were pushed
through a 100 μm mesh. CNS infiltrating cells were iso-
lated via a discontinuous 40/70% (v/v) Percoll gradient
(GE Healthcare).
Ex vivo T cell responses
Mixed splenocytes and lymph node cells were cultured
in 200 μl of RPMI 1640 containing 10% FBS, 2 mM L-
glutamine, 0.1 mM nonessential amino acids, 100 U
penicillin-streptomycin, 50 μM 2-mercaptoethanol, and
1 mM sodium pyruvate with or without 50 μg/ml MOG
peptide (amino acids 35-55) for 24 hrs. The cells were
incubated with brefeldin A (GolgiPlug, BD Bioscience)
for the last 5 hr.
Flow cytometry
Mixed splenocytes and lymph node cells were immunos-
tained immediately after isolation or after the 24 hour
culture described above. CNS mononuclear cells were
immunostained after incubation at 37°C for 3 hours in
RPMI 1640 containing 10% FBS, 2 mM L-glutamine, 0.1
mM nonessential amino acids, 100 U/mL penicillin-
streptomycin, 50 μM 2-mercaptoethanol, and 1 mM
sodium pyruvate in the presence of brefeldin A. Imme-
diately prior to immunostaining, Fc receptors were
blocked for 10 min with anti-CD16/32. Neutrophils
were identified by Fluorescein Isothiocyanate (FITC)-
labeled anti-mouse Ly-6G and Pe-Cy™7-labeled anti-
mouse Gr1 (BD pharmingen), macrophages or microglia
by Phycoerythrin (PE)-labeled anti-mouse CD45, BD
pharmingen and eFlour® 450-labeled anti-mouse CD11b
(eBioscience), and dendritic cells by Allophycocyanin
(APC)-labeled anti-mouse CD11c (BD Pharmingen). To
distinguish donor cells from recipient cells, cells were
co-stained with FITC labeled anti-mouse CD45.2 (BD
Table 1 Irradiation bone marrow chimeric mice (BMC)





Radiosensitive (peripheral immune) cells carry the genotype of donor mouse,
while radioresistant cells (all parenchymal cells including the CNS) carry the
genotype of the recipient mouse.
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pharmingen) and APC-labeled anti-mouse CD45.1
(eBioscience). For T helper (Th) and T cytotoxic (Tc)
cell subset analysis, cells were stained with Pacific Blue
(PB)-labeled anti-mouse CD4 and FITC-labeled anti-
mouse CD8a (BD pharmingen), fixed, permeabilized
using the Cytofix/Cytoperm Plus Kit (BD pharmingen)
according to the manufacturer’s protocol, and intracellu-
larly stained with APC-labeled anti-mouse IFNg, PE-
labeled anti-mouse IL17 and Pe-Cy™7-labeled anti-
mouse TNFa (BD pharmingen). Th1: CD4+IFNg+,
Th17: CD4+IL17+, Th1/17: CD4+IFNg+IL17+ Tc1: CD8
+IFNg+, Tc17: CD8+IL17+, Tc1/17: CD8+IFNg+IL17+.
For regulatory T lymphocyte (Treg, CD4+CD25+Foxp3
+) analysis, cells were stained with PB-labeled anti-
mouse CD4 and APC-labeled anti-mouse CD25
(eBioscience) with Fc receptor blocker, fixed, and per-
meabilized using the Fixation & Permiabilization kit
(eBioscience), then intracellularly stained with PE-
labeled anti-mouse/rat Foxp3 (eBioscience). Immunos-
tained cells were analyzed using a Cyan FACS (Dako
Cytomation).
Immunohistology of spinal cord and cerebellum/
brainstem
Mice were anesthetized and brains and spinal cords tis-
sues were harvested as described in the “Mapping areas
of blood brain barrier breakdown by Evans blue” section.
Harvested tissues were fixed overnight in 4% PFA,
immersed in 30% sucrose for 48 hours at 4°C and
embedded in cryostat mounting media (Tissue-Tek
OCT, Sakura Finetek). Tissues were coronally or sagit-
tally sectioned at 10 μm thickness. Sections were air-
dried at RT for 30 min, rinsed briefly with PBS, and
blocked with 10% of donkey or goat serum, depending
on the secondary antibody used. Some sections were
blocked with antibody diluent (IHC-Tek™). Sections
were incubated with primary antibodies listed in Table 2
overnight at 4°C and next day, with fluorescently conju-
gated secondary antibodies to DyLight™488 or
DyLight™549 (Jackson ImmunoResearch) for an hour at
RT. Between each step, the sections were washed
repeatedly with PBS for 5 min period to reduce back-
ground. Nuclei were visualized by DAPI counterstain.
Fluorescent images were analyzed by confocal micro-
scopy (Nikon A1). Microscopic fields were photo-
graphed with 20× or 40× objectives mounted on a
Nikon A1 scanning confocal microscope using the
Nikon NIS-Elements AR 3.10 software. Exposure was
adjusted per staining for all groups of mice using Adobe
Photoshop.
Quantification of SMI32+ axons, demyelinating foci, CD45R
+ cells or IL4+ cells
Fields encompassing the whole spinal cord or cerebel-
lum were photographed using a 20× objective mounted
on a Nikon laser scanning confocal microscope, and
images were tiled together using the Nikon NIS-Ele-
ments software. All SMI32+ axons in the white matter
of spinal cords and cerebella isolated from mice with
EAE were counted with the aid of NIH ImageJ software.
Demyelinating foci (absence of MBP staining) were
traced in the white matter of spinal cords and cerebella
isolated from mice with EAE were measured with the
aid NIS-Elements software. Total white matter areas
were measured in the cross-sections of cerebella or
spinal cords and were used for normalization in the
quantification of SMI32+ axons and demyelinating foci.
Total spinal cord or cerebellum cross-section areas were
used for normalization when quantifying CD45R+ or
IL4+ cells. Three 10 μm sections (40-50 μm apart from
each other) were counted per animal, n = 4 animals. To
determine statistical significance between the chimeric
groups a Kruskal-Wallis test with post-hoc Mann-Whit-
ney U tests with Bonferroni correction was performed.
Numbers of mice used in the study
Flow cytometry
WT and IFNg-/-: To calculate significance, p-values
were derived using the Mann-Whitney U test with Bon-
ferroni correction. The experiment was repeated 2-3
times, employing 3 mice per experiment for a total of 6-
9 mice per time-point per group.
Table 2 Primary antibodies used for
immunohistochemistry
Antigen Antibody
Ly6G FITC-conjugated rat anti-mouse Ly6G
BD Pharmingen (Cat#551460), 1:100
IBA1 Rabbit polyclonal anti-IBA1
Wako (Cat#019-19741), 1:1000
CD11b Rat anti-mouse CD11b
BD Pharmingen (Cat#550282), 1:100
CD4 Rat anti-mouse CD4
BD Pharmingen (Cat# 550280), 1:100
CD45.1 PE-conjugated mouse anti-mouse CD45.1
eBioscience (Cat#12-0453-82), 1:100
CD45.2 PE-conjugated mouse anti-mouse CD45.2
BD Pharmingen (Cat# 560695), 1:100
CD45.2 FITC-conjugated mouse anti-mouse CD45.2
eBioscience (Cat#11-0454-85)
SMI32 Mouse anti-mouse NF-H
Covance (Cat# SMI-32R), 1:1000
STAT1 Rabbit polyclonal anti-human STAT1
Santa Cruz (Cat# SC592), 1:100
CD45R PE-Texas Red rat anti-mouse CD45R/B220
BD Pharmingen (Cat# 551489), 1:100
IL4 Goat anti-mouse IL4
R&D (Cat# AF-404-NA)
MBP Rat anti-bovine myelin basic protein
Novus biologicals (Cat# NB600-717)
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IFNgRKO chimeras: To determine statistical signifi-
cance between the chimeric groups a Kruskal-Wallis
test with post-hoc Mann-Whitney U tests with Bonfer-
roni correction was performed. The experiment was
repeated 3 times employing 2 mice per experiment for a
total of 6 mice per time-point per group.
Immunohistochemistry
The experiment was repeated 2-3 times, employing 2-3
mice per experiment for a total of 4-9 mice per time-
point per group.
Results
Atypical neurological deficits initiate in the absence of
IFNg signaling in the CNS
Clinical course in wild type and IFNg -/- mice
Classic neurological deficits of EAE (ascending paralysis)
appeared both in IFNg-/- and wild-type (WT) controls
on or around day 10 post-immunization (pi). During the
chronic phase of EAE (post day 21), WT mice improved
slightly, but IFNg-/- mice continued to display severe
typical symptoms (Figure 1A). Atypical symptoms such
as head tilting, continuous axial rotation, and leaning
towards one side developed only in IFNg-/- mice, start-
ing on or a few days after the onset of the classic EAE
course (Figure 1B).
Clinical course in IFNgRKO chimeras
Classic neurological deficits appeared in all irradiation
bone marrow chimeric groups on or around day 11 pi.
IFNgRKO-chimeras, IFNgRCNSKO mice, and WT-chi-
meras showed classic deficits of similar severity through-
out the course of their illness, while IFNgRperiKO mice
displayed slightly milder disease severity during the
chronic phase of EAE (Figure 1C). Atypical neurological
deficits developed in 88% of IFNgRKO-chimeras on day
14.8 ± 0.5 (means ± SEM) but were not present in WT-
chimeras (Figure 1D). Interestingly, EAE induction in
mice without IFNg signaling in the CNS (IFNgRCNSKO)
resulted in the development of more severe and more
frequent atypical disease, that had an earlier onset than
mice without IFNg signaling in the periphery
Figure 1 EAE course in IFNg-/- and WT mice and IFNgR-KO chimeras. Classic (A and C) and atypical deficits (B and D) were monitored and
documented daily as described in the methods. Data are represented as means ± SEMs (A and B, n=51-54, C and D, n=13-20). *n/a: not
applicable, ** Average cumulative atypical score of mice with EAE up to day 20 post-immunization.
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(IFNgRperiKO): 78% of IFNgRCNSKO (day of onset 14.9 ±
0.5, and average cumulative score 5.3 ± 1.1) versus 31%
of IFNgRperiKO (day of onset 17.7 ± 1.4, and average
cumulative score 1.4 ± 0.4) developed atypical EAE (Fig-
ure 1D).
Peripheral immune responses and CNS leukocyte
accumulation are not correlated with the incidence of
atypical symptoms
To detect possible associations between atypical disease
and activation of peripheral immune cells and/or prefer-
ential recruitment of immune subsets into the CNS, we
isolated cells from lymphoid organs and from Percoll-
fractionated pooled brain and spinal cord of the various
groups of mice at the peak of disease (days 14-21 pi)
and analyzed them by flow cytometry as described in
the methods.
IFNg-/-/WT
Significantly increased numbers of peripheral MOG-spe-
cific Th17 cells were generated (Additional file 1) in
IFNg-/- mice compared to WT controls only on day 14
pi (p = 0.001). As expected, CD4+IFNg+ (Th1) CD4
+IFNg+IL17+ (Th1/17), CD8+IFNg+ (Tc1) and CD8
+IFNg+IL17+ (Tc1/17) cells were only observed in WT
controls and not in IFNg-/- mice. No other statistically
significant differences between the two groups were
observed in the numbers of immune cell subsets in per-
ipheral lymphoid organs (Additional file 1). In the CNS,
the numbers of neutrophils, total CD4+ T and Th17
cells were significantly increased in IFNg-/- mice as
compared to WT controls (Figure 2 A-C). These obser-
vations suggest that global absence of IFNg facilitates
the accumulation of neutrophils and CD4+ T cells in
the CNS, in agreement with previous studies [12,24,33].
Furthermore, the increased numbers of Th17 cells in
the CNS of IFNg-/- mice may imply preferential migra-
tion and/or (re)polarization of these cells within the
CNS; however, the decreased ratios of Tregs:Th17 in the
CNS of IFNg-/- mice as compared to WT mice (p =
0.007, Additional file 1) imply that in the absence of
IFNg, Tregs may not efficiently control the Th17-
induced neurotoxicity [34].
IFNgRKO chimeras
To determine the degree of chimerism, we used
CD45.1/CD45.2 allelic markers to identify host versus
donor infiltrating cells. All of the chimeric mice exhib-
ited 85-95% of donor cells in the periphery. Mice from
each chimeric group were randomly selected, sacrificed
6-8 weeks post reconstitution and mononuclear cells
were isolated from the CNS. We found that in the CNS
of chimeric mice, microglia were typically 85-95% of
recipient origin (data not shown). We were not able to
collect such data for IFNgRKO-chimeric mice since both
the recipient and donor cells carry the CD45.2 allele.
There were no significant differences between the four
groups of chimeric mice in the peripheral immune cell
subsets examined on days 14 and 21 pi. However, by
day 21, IFNgRKO chimeric mice tended to exhibit more
TNFa-producing cells in the periphery as compared to
the three other groups. In the CNS, the total numbers
of CD4+ and CD8+ T cells and microglia of the various
groups of chimeric mice were also comparable (Addi-
tional file 1). As in WT-mice, WT-chimeras and IFNgR-
periKO mice tended to exhibit higher Treg:Th17 ratios
compared to IFNgRKO-chimeras and IFNgRCNSKO
mice; however these differences did not reach statistical
significance. In addition, in the CNS of the IFNgRperiKO
mice CD8+ T cells were elevated but this again did not
reach statistical significance (Additional file 1).
Nevertheless, the differential expression of IFNgR did
influence the composition of the infiltrating immune
cells. On day 14, IFNgRperiKO mice had statistically sig-
nificantly lower numbers of Th17 in the CNS compared
to the rest of the chimeric groups (Figure 2F), which
was not due to defective Th17 cell generation in the
periphery of these mice (Additional file 1). However, by
day 21 all groups exhibited similar numbers of Th17
cells within the CNS.
Although there was no difference between the chi-
meric groups in the numbers of neutrophils (Ly6G+GR1
+) within the CNS at disease onset (day 14 pi), a week
later (day 21 pi), these numbers were significantly higher
in IFNgRKO-chimeras and IFNgRperiKO mice compared
to WT-chimeras and IFNgRCNSKO mice (Figure 2D).
Thus, the migration of neutrophils into the CNS was
IFNg-independent, but their maintenance in (or contin-
uous migration to) the CNS was facilitated by the
absence of IFNg signaling in peripheral immune cells.
B cells have been implicated in the generation of aty-
pical EAE [35]. B cells were quantified by immunohisto-
chemistry using an anti-CD45R antibody. As shown in
additional file 1, on day 14, B cells numbers were not
statistically significantly different between the chimeric
groups. On day 21 however, B cells number were statis-
tically significantly decreased in IFNgRCNSKO and
increased in IFNgRperiKO compared to WT-chimeras
and IFNgRKO-chimeras.
Expression of IFNgR in the CNS, independent of its
expression in the periphery, enhanced CNS accumula-
tion of infiltrating macrophages [WT-chimeras (CD11b
+CD45.1hiLy6G-) and IFNgRperiKO (CD11b+CD45.2hi-
Ly6G-)] both on days 14 and 21 (Figure 2E), suggesting
that macrophage migration cues are regulated by IFNg-
induced events within the CNS (e.g. chemokine expres-
sion by CNS resident cells).
Furthermore, IFNgRCNSKO mice showed a similar
composition of infiltrating cells (neutrophils, T cell sub-
sets) to WT-chimeras. These two groups exhibited
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differences in infiltrating macrophages but only on day
14: WT-chimeras showed increased numbers of infiltrat-
ing macrophages compared to both IFNgRCNSKO and
IFNgRKO-chimeras (Figure 2). On day 21, increased
numbers of macrophages observed in WT-chimeras
were statistically significantly different than those in
IFNgRKO chimeras but did not reach statistical signifi-
cance compared to those in IFNgRCNSKO mice. Macro-
phages showed the same trends in WT-chimeras and
IFNgRperiKO mice.
However, the composition of the infiltrates did not
directly affect the incidence of atypical neurological defi-
cits, since severe atypical deficits developed in both
IFNgRCNSKO and IFNgRKO chimeras, though the
makeup of CNS infiltrating cells differed dramatically
between these two mouse groups.
These observations suggest that the composition of
the CNS-infiltrating cells is determined by IFNg-
induced events taking place both in the periphery and
the CNS, but do not solely control the onset of atypi-
cal disease.
The spatial pattern of CNS infiltration is determined by
IFNg signaling in peripheral immune cells, but does not
correlate with the incidence of atypical EAE
Previous reports suggested that prominent cerebellar
and/or brainstem infiltration is sufficient to initiate aty-
pical symptoms in IFNg-/- mice with EAE [26,32]. To
evaluate this assumption, we compared the degree of
infiltration of the cerebella/brainstems of mice display-
ing atypical deficits with that of mice that developed
typical deficits only, after EAE induction. To determine
the areas of blood-brain barrier permeability, mice were
injected intravenously with Evans blue (Eb) within 24
hours after the onset of neurological deficits; 90 min
later, mice were perfused intracardially with PBS and
brains and spinal cords were analyzed as described in
the methods. All chimeric mice exhibited Eb staining in
similar areas of the CNS (Figure 3 and Additional file
2). However, the depth of parenchymal Eb infiltration
varied substantially between the groups. The CNS of
mice with global absence of IFNg signaling (IFNg-/- and
IFNgRKO chimeras) showed intense Eb intra-
Figure 2 Peripheral immune responses and CNS leukocyte accumulation are not correlated with the incidence of atypical symptoms.
Cell subsets isolated from Percoll-fractionated CNS (pooled spinal cord and brain) showing significant changes by flow cytometry between the
various groups of mice with EAE. Neutrophils (A) and Th17 cells (C) were significantly upregulated on days 14 and 21 pi, and total CD4+ T cells
on day 14 (B) in the CNS of IFNg-/- compared to WT controls. The CNS of IFNgRKO-chimeras and IFNgRperiKO mice, on day 21 (but not day 14) pi
was populated by greater numbers of neutrophils (Ly6G+GR1+) compared to WT-chimeras and IFNgRCNSKO mice (D). Infiltrating macrophages
were significantly upregulated only in the CNS of WT-chimeras (CD11b+CD45.1hiLy6G-) and IFNgRperiKO mice (CD11b+CD45.2hiLy6G-) both on
day 14 and 21 pi (E). Fewer Th17 cells were detected in the CNS of IFNgRperiKO mice compared to the other groups only on day 14 pi (F). Data
are presented as means ± SEMs, n = 6-9; significance was calculated using the Mann-Whitney test with Bonferroni correction for the WT and
IFNg-/- groups and with the non-parametric Kruskal-Wallis with post-hoc Mann-Whitney U test with Bonferroni correction for the IFNgRKO-
chimeric groups.
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Figure 3 BBB permeability does not correlate with onset of atypical disease. Representative Evans blue infiltrated areas of the cerebella/
brainstems and spinal cords of the various groups of mice at EAE onset. CNS areas showing Evans blue staining (see Additional file 2) were cut
transversely and photographed using a Zeiss stereoscope. Two (out of 4-6) representative mice per group are shown. IFNg-/- (A-D), IFNgRKO-
chimeras (I-L) and IFNgRperiKO (U-X) exhibited substantial Evans blue staining both in cerebellum and spinal cord. Evans blue staining patterns in
the WT (E-H), WT-chimeras (Q-T) and IFNgRCNSKO (M-P) were meningeal and confined in small areas in the spinal cord and were rarely detected
in the cerebellum/brainstem parenchyma. Numbers in pink and white denote atypical and classic neurological deficits, respectively.
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parenchymal staining, sometimes reaching the gray mat-
ter (Figure 3 A-D and 3I-L) both in the cerebellum/
brainstem and spinal cord. Similar Eb staining patterns
were observed in the CNS of IFNgRperiKO mice (Figure
3 U-X), extending deeply and broadly into the parench-
yma. Notably, IFNgRperiKO mice showed intense Eb
staining in the cerebellum and brainstem.
On the contrary, Eb+ foci in the CNS of WT mice,
WT-chimeras and IFNgRCNSKO mice were usually con-
fined to the meninges or minimally penetrating the glia
limitans into the superficial parenchyma (Figure 3E-H
and 3M-T). Furthermore, Eb staining in the parenchyma
of the cerebellum/brainstem of IFNgRCNSKO mice was
rarely observed.
As noted above, IFNgRCNSKO mice displayed more
frequent and more severe atypical deficits than IFNgRper-
iKO mice. Thus the intense Eb staining in the cerebella/
brainstem of IFNgRperiKO mice compared to
IFNgRCNSKO mice indicates that extensive infiltration of
these areas is not sufficient to elicit atypical EAE.
Composition of inflammatory foci within the CNS does
not affect the onset of atypical neurological deficits
Next, we tested the hypothesis that differential expres-
sion of IFNgR causes preferential accumulation of dis-
tinct immune cell subsets in specific CNS areas (e.g.
cerebellum versus spinal cord). We, thus, isolated cere-
bellar/brainstem, and spinal cord tissue from mice with
EAE and examined the composition of their inflamma-
tory foci by immunohistochemistry.
We used CD11b as a generic marker of inflammatory
foci. CD11b is easily detectable by immunohistochemis-
try on infiltrating macrophages, dendritic cells and neur-
tophils along with NK and some CD8+ T cells [36-40].
Microglia strongly express CD11b when activated but
do so only faintly when in resting state. We also used
the CD45 allelic markers CD45.1 and CD45.2 to discri-
minate between infiltrating cells and microglia in the
chimeric mice. Infiltrating CD11b+CD45.1+ cells in
IFNgRCNSKO mice and WT-chimeras cells remained
clustered and close to the vasculature and meninges
(Figure 4 A-D and Additional file 3). In the CNS of
IFNgRperiKO mice and IFNgRKO chimeras, infiltrating
CD11b+CD45.2+ cells were abundant and widely dis-
tributed throughout the CNS parenchyma (Figure 4 E-H
and Additional file 3). Neutrophils (Ly6G+) were abun-
dant in the CNS of all chimeric groups on day 14 (not
shown). On day 21, however, neutrophils were rarely
detected in the CNS of IFNgRCNSKO mice (Figure 4 I-L)
or WT mice and WT-chimeras (Additional file 4), but
remained prominent in the CNS lesions of IFNgRperiKO
mice (Figure 4 M-P) and of IFNg-/- mice and
IFNgRKO-chimeras (Additional file 4). Furthermore,
CD4+ T cells were more often found in perivascular
and meningeal spaces and close to the glial limitans,
and had only barely penetrated into the parenchyma in
the CNS of IFNgRCNSKO (Figure 4 Q-T) WT mice and
WT-chimeras (Additional file 5). On the contrary, CD4
+ T cells were usually found deep in the parenchyma in
the CNS of IFNgRperiKO (Figure 4 U-X), IFNg-/- and
IFNgRKO chimeras (Additional file 5),
Anti-IBA1 antibody labels more intensely activated
and quiescent microglia, and less intensely, infiltrating
macrophages. IBA1+ cells migrated to the site of infil-
tration and were in close contact with neutrophils and
CD4+ T cells (Figure 4), probably attempting to control
tissue damage. By staining for the CD45 allele markers
CD45.1/CD45.2, we verified that the cells interacting
with infiltrating CD4+T and Ly6G+ cells are of recipient
origin (i.e: microglia, Additional file 6).
In summary and in agreement with the Eb patterns,
these data show that infiltrates in IFNg-/-, IFNgRKO-
chimeras and IFNgRperiKO mice penetrated deeply into
the parenchyma and were widely scattered, whereas
inflammatory foci in WT mice, WT-chimeras and
IFNgRCNSKO mice were constrained to the perivascular
spaces and the meninges and tightly clustered together.
Lesion composition was similar in all mice, consisting of
CD4+T, CD11b+ and IBA1+ cells. The main difference
in the inflammatory foci between the groups of mice
was the persistence of Ly6G+ neutrophils in IFNg-/-
IFNgRKO chimeras and IFNgRperiKO a week after dis-
ease onset (day 21), at which time point they were spar-
sely observed in WT mice, WT-chimeras and
IFNgRCNSKO mice. These data, in agreement with our
flow cytometry results, indicate that the intra-lesion
composition is not directly associated with the onset of
atypical EAE. However, intense intercellular interactions
between microglia and infiltrating cells may play decid-
ing roles on the actions of peripheral cells after these
enter the CNS parenchyma.
The patterns of axonal degeneration are not linked to the
development of atypical symptoms
Cumulative axonal injury is largely responsible for the
development of permanent neurological disability in MS
patients and animals with EAE [1,2,41,42]. We specu-
lated that in the absence of IFNg signaling in the CNS,
axonal damage would be more severe, in the cerebellum
and brainstem (areas that control posture), or in areas
of the spinal cord, as unilateral damage of the spinal
cord has been associated with balance impairments,
such as leaning towards one side and disequilibrium
[43]. To detect axonal damage by immunohistochemis-
try, we used the SMI32 antibody, which is specific for
hypophosphorylated neurofilament H (hypo-NF-H).
Hypo-NF-H resides only in neuronal bodies of the gray
matter of the healthy spinal cord. In the healthy CNS,
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Figure 4 Composition of inflammatory foci in the CNS of mice with EAE does not correlate with onset of atypical disease. Mice were
sacrificed on day 21 pi and CNS infiltration was examined by immunohistochemistry. In IFNgRCNSKO mice CD11b+CD45.1+ infiltrating cells were
usually found perivascularly or close to the meninges (A-D). In IFNgRperiKO mice, CD11b+CD45.2+ infiltrating cells were found both in perivasular
spaces and deep into the parenchyma (E-H). There were few Ly6G+ neutrophils in the cerebella and spinal cords of IFNgRCNSKO mice (I-L) while
the same areas of IFNgRperiKO mice were characterized by prominent neutrophilic infiltration (M-P). IFNgRCNSKO exhibited decreased CD4+ T cell
parenchymal infiltration (Q-T) compared to IFNgRperiKO (U-X). Space bar = 50 μm. Inserts show magnified fields demonstrating close interactions
between IBA1+ and Ly6G + (I-P) or CD4+ (Q-X) cells (space bar = 10 μm). Nuclei were visualized by DAPI staining. Two (out of 4-6)
representative mice per set are shown.
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SMI32 immunoreactivity is not detected in the white
matter (Additional file 7). SMI32 immunoreactivity,
within the white matter is indicative of accumulation of
hypo-NF-H in axons, reflecting axonal flow distur-
bances, degeneration or transection [1,44].
The pattern of SMI32 immunoreactivity in the white
matter correlated with the degree of infiltration. Axonal
damage occurred only within and around inflammatory
foci. Thus, IFNg-/- mice, IFNgRKO-chimeras and
IFNgRperiKO mice showed intense SMI32 immunoreac-
tivity both in the cerebellum and spinal cord compared
to WT mice, WT-chimeras IFNgRCNSKO mice (Figure
5, Additional file 7). However, quantification of SMI32
immunoreactive axons within the white matter of chi-
meric mice with EAE did not show statistically signifi-
cant differences between the groups (Additional file 7).
Quantification of demyelinating foci in the same sec-
tions visualized by absence of myelin basic protein
(MBP) showed no difference between the groups in the
spinal cord. Interestingly, however, the cerebellum of
IFNgRCNSKO mice with EAE exhibited smaller and
fewer areas of demyelinating foci (Additional File 8),
although this did not reach statistical significance (p =
0.0522).
These data indicate that the pattern of axonal damage
as detected by accumulation of hypo-NF-H in the white
matter could not account for the onset of atypical neu-
rological deficits. However, in the CNS of all bone mar-
row chimeric mice with EAE, IBA1+ microglia were
found in close contact with neuronal perikarya and
axons (Figure 5 and Additional file 7), suggesting that
these intercellular communications affect neuronal
function.
Atypical neurological deficits develop preferentially in the
absence of microglial IFNgR-STAT1 signaling
STAT1 is upregulated in the CNS only in response to IFNg
In the absence of reliable antibodies against IFNgR for
immunohistochemistry, to identify the cell type(s) that
respond to IFNg signaling we examined the expression
patterns of the transcription factor STAT1 that is down-
stream from IFNgR. STAT1 was not detected in the
healthy CNS (Additional file 9). To confirm that STAT1
is upregulated only in cells that express IFNgR, we initi-
ally examined STAT1 expression by co-labeling for
CD45.1 or CD45.2. In IFNgRKO-chimeras, both micro-
glia and infiltrating cells carried the CD45.2 allele.
STAT1 was rarely detected and only within inflamma-
tory foci (Figure 6 A-D). On the contrary, WT-chimeras
with EAE showed abundant STAT1 expression in both
infiltrating (CD45.1+) and resident cells (CD45.1-) (Fig-
ure 6 I-L). In the CNS of IFNgRCNSKO mice with EAE,
Figure 5 Axonal damage, as visualized by SMI32+ axons in the white matter, correlates with inflammatory foci but not with atypical
EAE. Cerebella and spinal cords isolated on day 21 pi were analyzed for axonal damage by immunoreactivity for SMI32 antibody. SMI32+ axons
were detectable in the white matter only within or around inflammatory foci. SMI32 immunoreactivity was less intense in cerebella and spinal
cords of IFNgRCNSKO (A-D) compared to IFNgRperiKO (E-H). Space bar = 50 μm. Inserts show magnified areas of the gray matter depicting
microglia (IBA1+) in close contact with neuronal bodies (SMI32+). Space bar = 10 μm. Nuclei were visualized by DAPI staining. Two (out of 4-6)
representative mice per set are shown.
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Figure 6 STAT1 expression is detected mainly in IFNgR+ cells. Panels show areas of inflammatory foci or normal appearing white/gray
matter (NAW/GM) areas away from the site of inflammation. Infiltrating cells are shown in red (CD45.2 for A-D and M-P or CD45.1 for E-L).
IFNgRKO-chimeras expressed CD45.2 both in the CNS and periphery, and STAT1 was rarely detected in isolated cells within infiltrating foci (A, C)
or in the normal appearing white/gray matter (NAW/GM) areas away from the site of inflammation (B, D). IFNgRCNSKO mice exhibited STAT1
expression in CD45.1+(IFNgR+) infiltrating cells (E, G) and not in the NAW/GM (F, H). WT-chimeras expressed STAT1 both in CD45.1+ (IFNgR+)
infiltrating cells and CD45.1-(IFNgR+) resident cells (I-L), while in IFNgRperiKO mice, STAT1 expression was mainly absent from CD45.2+(IFNgR-)
infiltrating cells (M, O) but was localized in CD45.2-(IFNgR+) resident cells in NAW/GM (N, P). Space bar = 50 μm. Inserts show selected magnified
fields. Space bar = 10 μm. Nuclei were visualized by DAPI staining. Two (out of 4-6) representative mice per set are shown.
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infiltrating CD45.1+ (IFNgR+), but not resident CD45.1-
(IFNgR-) cells, expressed STAT1 (Figure 6 E-H). In
IFNgRperiKO mice, STAT1 was expressed by resident
CD45.2- (IFNgR+) but not infiltrating CD45.2+ (IFNgR-)
cells (Figure 6 M-P). These observations indicated that
in the inflamed CNS, STAT1 is specifically upregulated
in response to IFNg signaling.
IFNg signals mainly in CD11b+ cells in the inflamed CNS
Further examination revealed that STAT1 was upregu-
lated mainly in CD11b+ cells with intact IFNg signaling
(Figure 7). STAT1 was almost absent in the CNS par-
enchyma of IFNg-/- and IFNgRKO chimeras with EAE,
although CD11b immunoreactivity was abundant (Figure
7 A-D and 7I-L). In WT mice and WT-chimeras with
EAE, STAT1 immunoreactivity was abundant in CD11b
+ cells in inflammatory foci representing infiltrating
cells and activated microglia, both in the cerebellum and
the spinal cord (Figure 7 E, G and 7Q, S). Furthermore
CD11b+ cells with ramified morphology further from
the site of inflammation in the otherwise normal
appearing white and gray matter were also STAT1 posi-
tive (Figure 7 F, H and 7R, T). This suggests that micro-
glia respond to IFNg signaling even when they are not
in close contact with infiltrating cells. In IFNgRCNSKO
mice, STAT1 was upregulated in CD11b+ cells within
the inflammatory foci (IFNgR+) but not in CD11b+ resi-
dent cells (IFNgR-) (Figure 7 M-P). In IFNgRperiKO
mice, STAT1 expression was prevalent in CD11b+ cells
with microglial morphology (resident cells, IFNgR+) and
not in infiltrating cells (IFNgR-) in the white matter
(Figure 7 U-X). Occasionally, STAT1 expression was
detected in GFAP+ cells (astrocytes) found close to
inflammatory foci, but only in the presence of intact
IFNg signaling within the CNS (Additional file 10).
Furthermore, STAT1 was usually found within the
nucleus, suggesting activation of the STAT1 trancription
process (Additional File 11).
These data clearly show that, IFNg-elicited STAT1
responses in the inflamed CNS are largely restricted to
CD11b+ cells. Absence of STAT1 in infiltrating CD11b+
cells does not correlate to a large extent with the onset
of atypical EAE (IFNgRperiKO mice). On the contrary,
atypical neurological deficits are strongly associated with
inactivation of the IFNg-STAT1 signaling pathway in
microglia (IFNgRCNSKO mice).
Discussion
In the past, the development of atypical EAE in mice
without IFNg signaling has been attributed to preferen-
tial infiltration of the cerebellum and/or brainstem by
activated immune cells, increased generation of Th17
cells in the periphery, and/or formation of neutrophil-
rich posterior fossa inflammatory foci [24,45-47]. To a
large extent, these conclusions were derived from
studies of adoptively transferred EAE, a paradigm that
does not allow for clear discrimination of immune cells
derived from the donor and host. Therefore, to discrimi-
nate between the actions of IFNg in the CNS and the
periphery, we constructed irradiation bone marrow chi-
meric mice lacking IFNgR in CNS cells but not periph-
eral immune cells or vice versa. After EAE induction,
mice without IFNgR in radioresistant CNS cells
(IFNgRCNSKO) had more severe and more frequent aty-
pical neurological deficits as compared to mice lacking
IFNgR in radiosensitive peripheral immune cells (IFNgR-
periKO). Histological and flow cytometry analysis showed
that lesion distribution, inflammatory cell populations
within the CNS and intra-lesion composition of the
inflammatory foci did not correlate with the incidence
of atypical EAE. In contrast to what we had anticipated,
cerebellar/brainstem areas of IFNgRCNSKO mice exhib-
ited low levels of infiltration while the same areas of
IFNgRperiKO mice were heavily populated by peripheral
immune cells. Furthermore, the numbers of Th17 cells
and neutrophils in the CNS did not correlate with the
presence or absence of atypical EAE. In conjunction
with the previous studies mentioned above, our observa-
tions indicate that although cerebellar/brainstem infil-
trates of neutrophils and Th17 cells may be necessary to
cause atypical EAE, they are not sufficient alone to do
so. This led us to the conclusion that the CNS resident
cell responses in the absence of IFNg signaling may be
responsible for the onset of atypical EAE.
We used STAT1 as a surrogate marker to identify
cell targets of IFNg signaling. STAT1 was detected
mainly on CD11b+ cells, both in the inflammatory foci
and in normal appearing white and gray matter.
Although we can not exclude STAT1-independent
events, these data show that IFNg actions in the CNS
are exerted in microglia and infiltrating CD11b+ cells.
Furthermore, IFNgRCNSKO mice with severe atypical
EAE showed virtually no STAT1 expression in micro-
glia, but STAT1 upregulation was detected in infiltrat-
ing CD11b+ cells. On the contrary, STAT1 was not
detected in infiltrating CD11b+ cells, but was widely
expressed in microglia in IFNgRperiKO mice, which
showed mild or no atypical deficits. These data suggest
that deletion of IFNg signaling in microglia, but not in
infiltrating CD11b+ cells, correlates with atypical EAE.
This conclusion is further strengthened by the prior
observation that mice without STAT1 suffer a fulmi-
nant form of EAE [46].
Microglia (IBA1+ cells that were of host origin as veri-
fied by immunohistochemistry for the appropriate CD45
allele) were closely apposed to infiltrating CD4+ and
Ly6G+ cells in the CNS of EAE mice, and thus may
have modulated the properties of these peripheral
immune cells after their entry into the CNS [48,49].
Lee et al. Journal of Neuroinflammation 2012, 9:7
http://www.jneuroinflammation.com/content/9/1/7
Page 13 of 17
Figure 7 STAT1 is mainly expressed in CD11b+ cells. Cerebella and spinal cords isolated from the different groups of mice on day 14 post
EAE induction were analyzed for STAT1 expression close to the inflammatory foci and in the normal appearing white or gray matter (NAW/GM).
In the CNS of IFNg-/- mice and IFNgRKO-chimeras STAT1 expression was rarely detected, while CD11b+ cells were abundant both in the
cerebellum and spinal cord (A-D, I-L). STAT1 expression was readily detectable in the CNS of WT mice and WT-chimeras both within the
inflammatory foci (E, G, Q and S) and in the NAW/GM (F, H, R and T). In IFNgRCNSKO mice, STAT1 expression was prominent in CD11b+ cells
within the inflammatory foci (M, O), while it was rarely detected in CD11b+ cells with ramified morphology away from the inflammatory lesions
(N, P). In the CNS of IFNgRperiKO mice, the majority of CD11b+ cells with amoeboid morphology (activated microglia or macrophages) in the
inflammatory foci did not express STAT1 (U, W). STAT1 was mainly expressed by CD11b+ cells located in the normal appearing gray matter,
exhibiting morphology similar to that of ramified microglia (V, X). Space bar = 50 μm. Inserts show selected magnified fields to confirm STAT1
upregulation. Space bar = 10 μm. Nuclei were visualized by DAPI staining. Two (out of 4-6) representative mice per set are shown.
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Activated microglia were also in close contact with
neuronal perikarya and axons in the EAE mice. Upon
activation, microglia may either promote neurogenesis,
and support neuronal function [50-52], or accelerate or
induce damage [53-55]. It is likely that in the absence of
IFNg signaling microglia become neurotoxic causing
damage in spinocerebellar, cerebrospinal and propriosp-
inal tracts that control balance and posture; these tracts
transverse both the brain stem and the spinal cord.
Damaged axons are most abundant in and around
inflammatory foci in EAE, and are likely to contribute
to motor deficits such as ascending paralysis [1]. How-
ever, the extent of axonal damage as detected by SMI32
immunoreactivity in the cerebellum and spinal cord was
not correlated with the incidence of atypical EAE,
though it is possible that axonal and neuronal damage
detectable by techniques other than SMI32 immunos-
taining (e.g., alterations in mitochondrial morphology
[56], dysregulated Na+ channel expression [57], or dis-
ruption of neuronal microtubule network [44]) may
prove to be associated with atypical neurological deficits.
Our data suggest that, in the inflamed CNS, IFNgR-
STAT1 signaling is one of the factors that determines
whether microglia acquire a neuroprotective or neuro-
toxic properties. Though the extent of neuronal death
was minimal and not different in the cerebella and
spinal cords of the various chimeric mice as assessed by
TUNEL (data not shown) we suspect that IFNgR defi-
cient microglial responses induce physiological altera-
tions in the properties of specific subsets of cerebellar/
brainstem neurons that lead to circling [58] and other
atypical neurological symptoms.
Conclusions
In the present study, we demonstrated that in EAE the
development of deficits associated with vestibular dys-
function is not dependent solely on cerebellar and
brainstem infiltration by peripheral immune cells, or the
composition and localization of inflammatory foci within
the CNS. Our data support the hypothesis that inhibi-
tion of IFNg actions mediated through microglial
STAT1 is the main direct (cross-talk with neurons) or
indirect (cross-talk with infiltrating cells, or astrocytes)
cause for the onset of atypical neurological deficits.
Modulation of IFNg-STAT1 responses in microglia
might prove a promising therapy for cerebellar/vestibu-
lar dysfunction in neuroinflammatory disorders.
Additional material
Additional file 1: Table 1: Immune cell subsets in periphery (MOG-
recall) and the CNS of IFNg-/- and WT mice with EAE. P values were
calculated using Mann-Whitney U test with Bonferroni correction.
Six to nine mice were analyzed per time point in each group. Table 2:
Immune cell subsets in periphery and the CNS of the chimeric mouse
groups with EAE. P values were calculated using Kruskal-Wallis test with
post-hoc Mann-Whitney U tests with Bonferroni correction. Six mice
were analyzed per group in each time point.
Additional file 2: Macroscopic photographs showing BBB
permeability. Macroscopic photographs of spinal cords and brains
isolated up to 24 hrs post the onset of neurological deficits and 90
minutes after Evans blue intravenous administration. Tissues were
photographed using the Zeiss SteREO Lumar.V12 stereoscope and tiled
together using Photoshop.
Additional file 3: CD11b+ cells distribution in the inflamed CNS.
CD11b+ cells were abundant in the cerebella and spinal cords of
IFNgRKO-chimeras and WT chimeras on day 21 pi. CD11b+CD45.2+ cells
were found within the CNS parenchyma of IFNgRKO-chimeric mice (both
infiltrating and resident microglia express CD45.2 in this chimeric group,
A-D). In the CNS of WT-chimeras, infiltrating CD45.1+CD11b+ cells (E-H)
were usually found perivascularly or close to the meninges. Nuclei were
visualized by DAPI staining. Two (out of 4-6) representative mice per set
are shown. Space bar = 50 μm.
Additional file 4: Neutrophil distribution in the inflamed CNS. On
day 21 pi, cerebella and spinal cords of IFNg-/- mice were heavily
populated by Ly6G+ neutrophils (A-D), while the same areas of WT mice
exhibited low level and spatially confined neutrophilic infiltration (E- H).
Ly6G+ neutrophils were abundant in the cerebella and spinal cords of
IFNgRKO-chimeras (I-L) but only sparsely detected in WT-chimeras (M-P).
Nuclei were visualized by DAPI staining. Space bar = 50 μm. Inserts show
magnified fields demonstrating close interactions between IBA1+ and
Ly6G+ cells (space bar = 10 μm). Two (out of 4-6) representative mice
per set are shown.
Additional file 5: CD11b+ cells distribution in the inflamed CNS.
Cerebella and spinal cords of IFNg-/- (A-D) and IFNgRKO-chimeras (I-L)
exhibited increased parenchymal infiltration by CD4+T cells compared to
WT (E-H), and WT-chimeras (M-P), respectively. Two (out of 4-6)
representative mice per set are shown. Nuclei were visualized by DAPI
staining. Space bar = 50 μm. Inserts show magnified fields
demonstrating close interactions between IBA1+ and CD4+ cells (space
bar = 10 μm).
Additional file 6: Resident microglia interact with infiltrating cells.
Resident microglia cells identified by CD45.2 (pseudo green) for
IFNgRCNSKO (A, B, G, H) and WT-chimeras (C, D, I, J) or CD45.1(pseudo
green) IFNgRperiKO (E, F, K, L) closely interact with CD4+ (A-F) and Ly6G+
(G-L) infiltrating cells (pseudo red). Two (out of 4-6) representative mice
per set are shown. Nuclei were visualized by DAPI staining. Space bar =
50 μm.
Additional file 7: Axonal damage as visualized by SMI32+ axons in
the white matter does not correlate with atypical EAE. Spinal cords
and cerebella isolated from healthy mice and EAE mice on day 21 pi
were analyzed for axonal damage by immunoreactivity for
hypophosphorylated neurofilament-H in the white matter, using the
SMI32 antibody. SMI32+ axons were not detected in the healthy white
matter (A-D). SMI32 immunoreactivity is readily detected in healthy
neuronal bodies within the gray matter (inserts in panels A-D). SMI32+
axons were detectable in the white matter only within or around the
inflammatory foci and were more intense in the cerebella and spinal
cords of IFNg-/- mice (E-H), and IFNgRKO-chimeras (M-P) compared to WT
mice (I-L), and WT-chimeras (Q-T). IBA1+ cells were found in close
proximity to SMI32+ axons in the white matter in all groups of mice.
Nuclei were visualized by DAPI staining. Two (out of 4-6) representative
mice per set are shown. Space bar = 50 μm. Inserts show magnified
areas of the gray matter depicting IBA1+ cells in contact with neuronal
bodies. Space bar = 10 μm. Panel U shows the quantification of SMI32+
axons per mm2 of white matter of spinal cords or cerebella isolated from
the chimeric mouse groups with EAE on day 21.
Additional file 8: Loss of myelin does not correlate with the onset
of atypical neurological dificits. Fields encompassing the whole spinal
cord or cerebellum, isolated from chimeric groups with EAE on day 21
and stained with anti-MBP antibody, were photographed using a 20X
objective mounted on a Nikon laser scanning confocal microscope, and
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images were tiled together using the Nikon NIS-Elements. MBP negative
areas were traced and quantified using the ImageJ software. Panels A-H
show representative cerebellar and spinal cord sections stained with
MBP; areas of demyelination are traced in white and white matter is
traced in green. Panel I shows the quantification of MBP-negative areas
as mm2/mm2 of white matter. On day 14, IFNgRCNSKO mice showed
fewer and smaller demyelinating foci compare to the other groups and
this difference approached statistical significance (p = 0.0522). No other
statistically significant difference was observed between the groups.
Additional file 9: STAT1 was not detected in healthy CNS of non-
irradiated (A-D) or chimeric (E-H) mice. CD11b immunoreactivity was
not detected in healthy CNS, since microglia are not activated. Nuclei
were visualized by DAPI staining. Space bar = 50 μm.
Additional file 10: STAT1 is expressed only in few GFAP+ astrocytes
usually close to inflammatory foci. STAT1 was not detected in GFAP+
astrocytes in IFNg-/- (A-D) or IFNgRKO chimeras (I-L). In the CNS of
IFNgRCNSKO (M-P) and IFNgRperiKO (U-X), GFAP+ cells rarely expressed
STAT1, but were routinely found in close contact with STAT1 expressing
cells. STAT1 was occasionally detected in astrocytes close to a lesion in
the CNS of WT mice (E-H) and WT-chimeras (Q-T). Nuclei were visualized
by DAPI staining. Two (out of 4-6) representative mice per set are shown.
Space bar = 50 μm. Inserts show magnified fields. Space bar = 10 μm.
Additional file 11: STAT1 translocates to the nucleus. Sections
isolated from the cerebellum and spinal cord of chimeric mice with EAE
were stained with anti-STAT1 (green) and anti-CD11b (red). The sections
were imaged using a 60× objective mounted on a Nikon laser scanning
confocal microscope. Panels A, B, C and D are stacked images of 14
sequential planes each 0.7 μm thick. Panels A’ B’ C’ and D’ are single
plane orthogonal confocal images showing STAT1 translocation into the
nucleus. Nuclei were visualized by DAPI staining. Space bar = 50 μm.
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